课题基金 / 基金详情

HYPOLIPIDEMIC EFFECTS OF SIMVASTATIN/FLUVASTATIN IN HYPERCHOLESTEROLEMICS

HYPOLIPIDEMIC EFFECTS OF SIMVASTATIN/FLUVASTATIN IN HYPERCHOLESTEROLEMICS
辛伐他汀/氟伐他汀对高胆固醇血症患者的降血脂作用
批准号：
5220262
负责人：
D ROGER ILLINGWORTH
金额：
$0.0万
依托单位：
--
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/5220262
关键词：
antihypercholesterolemic agent blood disorder chemotherapy clinical research clinical trials drug adverse effect drug screening /evaluation human subject human therapy evaluation hypercholesterolemia lovastatin steroid biosynthesis

项目摘要

项目成果

D ROGER ILLINGWORTH的其他基金

相关文献

中文摘要
翻译
这项研究将评估降胆固醇的效果和影响 25~30岁辛伐他汀和氟伐他汀胆固醇生物合成的研究 中度原发性高胆固醇血症患者。五周后 饮食基线，患者将接受三种积极的药物治疗 潜在剂量辛伐他汀(5、10或20 mg/天)或氟伐他汀(20 mg/天) 或40毫克/天)。患者将接受这五种治疗中的三种 每个期权为期五周。
英文摘要
This study will evaluate the hypocholesterolemic effects and influence on cholesterol biosynthesis of simvastatin and fluvastatin in 25-30 patients with moderate primary hypercholesterolemia. After a five week dietary baseline, patients will receive active drug therapy with three potential doses of simvastatin (5, 10, or 20 mg/day) or fluvastatin (20 or 40 mg/day). Patients will receive three of these five treatment options each for a period of five weeks.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Effects of simvastatin on postprandial hyperlipidemia
REGULAR AND SUSTAINED RELEASE SIMVISTATIN IN HYPERCHOLESTEROLEMIA
SIMVASTATIN ON STEROID HORMONE PRODUCTION IN MEN WITH HYPERCHOLESTEROLEMIA
THE EFFECTS OF HIGH DOSE SIMVASTATIN IN PRIMARY HYPERCHOLESTEROLEMIA